|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
24
|
|
pubmed:dateCreated |
2006-8-21
|
|
pubmed:abstractText |
Within the last two decades, a new understanding of the biology of myelodysplastic syndrome (MDS) has developed. With this understanding, new classification systems, such as the WHO diagnostic criteria, and the International Prognostic Scoring System and response criteria guidelines reported by the International Working Group (IWG) have been developed. We report the combined results of three previously reported clinical trials (n = 309) with azacitidine using the WHO classification system for MDS and acute myeloid leukemia (AML) and IWG criteria for response.
|
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/CA02599,
http://linkedlifedata.com/resource/pubmed/grant/CA03927,
http://linkedlifedata.com/resource/pubmed/grant/CA04326,
http://linkedlifedata.com/resource/pubmed/grant/CA04457,
http://linkedlifedata.com/resource/pubmed/grant/CA07968,
http://linkedlifedata.com/resource/pubmed/grant/CA08025,
http://linkedlifedata.com/resource/pubmed/grant/CA11789,
http://linkedlifedata.com/resource/pubmed/grant/CA12046,
http://linkedlifedata.com/resource/pubmed/grant/CA12449,
http://linkedlifedata.com/resource/pubmed/grant/CA16450,
http://linkedlifedata.com/resource/pubmed/grant/CA21060,
http://linkedlifedata.com/resource/pubmed/grant/CA26806,
http://linkedlifedata.com/resource/pubmed/grant/CA31946,
http://linkedlifedata.com/resource/pubmed/grant/CA31983,
http://linkedlifedata.com/resource/pubmed/grant/CA32291,
http://linkedlifedata.com/resource/pubmed/grant/CA33601,
http://linkedlifedata.com/resource/pubmed/grant/CA35279,
http://linkedlifedata.com/resource/pubmed/grant/CA37135,
http://linkedlifedata.com/resource/pubmed/grant/CA41287,
http://linkedlifedata.com/resource/pubmed/grant/CA47545,
http://linkedlifedata.com/resource/pubmed/grant/CA47555,
http://linkedlifedata.com/resource/pubmed/grant/CA47559,
http://linkedlifedata.com/resource/pubmed/grant/CA47577,
http://linkedlifedata.com/resource/pubmed/grant/CA47642,
http://linkedlifedata.com/resource/pubmed/grant/CA52784,
http://linkedlifedata.com/resource/pubmed/grant/CA60138,
http://linkedlifedata.com/resource/pubmed/grant/CA77406,
http://linkedlifedata.com/resource/pubmed/grant/CA77440
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3895-903
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16921040-Antimetabolites, Antineoplastic,
pubmed-meshheading:16921040-Azacitidine,
pubmed-meshheading:16921040-Blood Transfusion,
pubmed-meshheading:16921040-Humans,
pubmed-meshheading:16921040-Infusions, Intravenous,
pubmed-meshheading:16921040-Injections, Subcutaneous,
pubmed-meshheading:16921040-Multicenter Studies as Topic,
pubmed-meshheading:16921040-Myelodysplastic Syndromes,
pubmed-meshheading:16921040-Randomized Controlled Trials as Topic,
pubmed-meshheading:16921040-Retrospective Studies,
pubmed-meshheading:16921040-Survival Analysis,
pubmed-meshheading:16921040-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B.
|
|
pubmed:affiliation |
Division of Hematology/Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA. lewis.silverman@mssm.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
